Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcus Biosciences, Inc.(RCUS) | 31,424,760 | 31,424,760 | 0 | $968.83M | $811.70M | 55.45% | -$157.12M |
| Lakefront Biotherapeutics NVADR(LKFT) | 16,707,477 | 16,707,477 | 0 | $500.16M | $501.28M | 34.24% | +$1.13M |
| Assembly Biosciences Inc. | 4,977,089 | 4,977,089 | 0 | $136.77M | $116.91M | 7.99% | -$19.86M |
| Kyverna Therapeutics Inc. | 4,126,119 | 4,126,119 | 0 | $36.76M | $28.06M | 1.92% | -$8.71M |
| Xilio Therapeutics Inc. | 650,389 | 650,389 | 0 | $6.23M | $5.89M | 0.40% | -$344.7K |